{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T04:27:48Z","timestamp":1648528068667},"reference-count":9,"publisher":"Elsevier BV","issue":"1","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.neurol.2013.06.004","type":"journal-article","created":{"date-parts":[[2013,10,11]],"date-time":"2013-10-11T19:51:00Z","timestamp":1381521060000},"page":"2-5","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Traitement d\u2019induction dans la scl\u00e9rose en plaques\u00a0: place du natalizumab"],"prefix":"10.1016","volume":"170","author":[{"given":"A.","family":"Corlob\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Charif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Outteryck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"de S\u00e8ze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Labauge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.neurol.2013.06.004_bib0005","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1177\/1352458509106230","article-title":"Serial combination therapy: is immune modulation in multiple sclerosis enhanced by initial immune suppression?","volume":"15","author":"Bar-Or","year":"2009","journal-title":"Mult Scler"},{"key":"10.1016\/j.neurol.2013.06.004_bib0010","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1468-1331.2010.03112.x","article-title":"Natalizumab induces a rapid improvement of disability status and ambulation after failure of previous therapy in relapsing-remitting multiple sclerosis","volume":"18","author":"Belachew","year":"2011","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2013.06.004_bib0015","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1056\/NEJMoa1107829","article-title":"Risk of natalizumab-associated progressive multifocal leukoencephalopathy","volume":"366","author":"Bloomgren","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurol.2013.06.004_bib0020","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(12)61769-3","article-title":"Alemtuzumb versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3\u00a0trial","volume":"380","author":"Cohen","year":"2012","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.neurol.2013.06.004_bib0050","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1136\/jnnp.2010.229724","article-title":"Mitoxantrone prior to interferon beta-1b in agressive relapsing multiple sclerosis: a 3-year randomised trial","volume":"82","author":"Edan","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2013.06.004_bib0030","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00415-009-0093-1","article-title":"The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL","volume":"256","author":"Hutchinson","year":"2009","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2013.06.004_bib0035","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1468-1331.2008.02517.x","article-title":"Efficacy of natalizumab in multiple sclerosis patients with high disease activity: a Danish nationwide study","volume":"16","author":"Oturai","year":"2009","journal-title":"Eur J Neurol"},{"issue":"11","key":"10.1016\/j.neurol.2013.06.004_bib0040","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1111\/j.1468-1331.2010.03178.x","article-title":"Natalizumab treatment in paediatric multiple sclerosis: a case of induction, de-escalation and escalation","volume":"17","author":"Putzki","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2013.06.004_bib0045","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000276400","article-title":"Natalizumab reduces clinical and MRI activity in multiple sclerosis patients with high disease activity: results from a multicenter study in Switzerland","volume":"63","author":"Putzki","year":"2010","journal-title":"Eur Neurol"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378713009132?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378713009132?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T02:57:37Z","timestamp":1539313057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378713009132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0035378713009132"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2013.06.004","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Traitement d\u2019induction dans la scl\u00e9rose en plaques\u00a0: place du natalizumab","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2013.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}